Clinical Trials Directory

Trials / Terminated

TerminatedNCT00673270

Effects of Fludrocortisone and Hydrocortisone in Healthy Volunteers With Aldosterone Induced Suppression

Hemodynamic and Biological Effects of Fludrocortisone and Hydrocortisone, in Healthy Volunteers With Aldosterone Induced Suppression

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
Male
Age
20 Years – 30 Years
Healthy volunteers
Accepted

Summary

Septic shock (associated with relative adrenal insufficiency) is characterized by decreased arterial responsiveness to catecholamines. The association of hydrocortisone and fludrocortisone has demonstrated an improvement in survival in septic shock patients. If hydrocortisone has shown to increase vascular responsiveness, the role of fludrocortisone remains to be elucidated. The purpose of our study is to investigate the effect of a physiological dose of fludrocortisone and/or hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in healthy volunteers with aldosterone suppression induced by intravenous sodium loading.

Conditions

Interventions

TypeNameDescription
DRUGFludrocortisone50 µg of fludrocortisone per os
DRUGHydrocortisone50 mg of intravenous hydrocortisone
DRUGPlacebo of FludrocortisoneTablet of placebo of Fludrocortisone
DRUGPlacebo of Hydrocortisone2 ml of isotonic saline solution

Timeline

Start date
2008-05-01
Primary completion
2008-10-01
Completion
2009-03-01
First posted
2008-05-07
Last updated
2012-03-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00673270. Inclusion in this directory is not an endorsement.